Case Report | Open Access
Rahman Nakshabendi, Andrew C. Berry, Daisy Torres-Miranda, Francis Daniel LaBarbera, Ozdemir Kanar, Ahmad Nakshabandi, Imad Nakshabendi, "Primary Histoplasma capsulatum Enterocolitis Mimicking Peptic and Inflammatory Bowel Disease", Case Reports in Gastrointestinal Medicine, vol. 2016, Article ID 7139573, 3 pages, 2016. https://doi.org/10.1155/2016/7139573
Primary Histoplasma capsulatum Enterocolitis Mimicking Peptic and Inflammatory Bowel Disease
In immunocompromised patients, histoplasmosis may present as disseminated disease. We present a 52-year-old Caucasian male with symptoms of dyspepsia, postprandial epigastric pain, nausea, and nonbloody diarrhea. Upper and lower gastrointestinal endoscopies were suspicious for inflammatory bowel disease (IBD); however, biopsies were consistent with histoplasmosis, specifically in the duodenum.
Histoplasma capsulatum is a dimorphic fungus that infects by inhalation of spores and can disseminate to the gastrointestinal system. Immunocompetent patients that acquire histoplasmosis generally have a self-limited respiratory infection [1, 2]. Patients who are immunosuppressed are unable to develop effective cell-mediated immunity against the organism and are likely to manifest symptomatic disease during the period of acute dissemination. Gastrointestinal histoplasmosis (GIH) is common in patients with primary lung involvement, but it is very unusual to present with isolated involvement of the gastrointestinal system.
2. Case Presentation
A 52-year-old Caucasian male with no pertinent past medical history presented with dyspepsia, nausea, bloating sensation, and postprandial abdominal pain, associated with nonbloody watery-brown diarrhea for six weeks. He also reported decreased appetite and unintentional weight loss of about 30 pounds (13.6 kg) in the last two months. He denied use of NSAIDS, coffee, alcohol, tobacco, or illicit drugs, any recent travel, or sick contacts. Vital signs were within normal limits. Physical exam was unremarkable except palpation eliciting mild diffuse pain in all four quadrants without rebound tenderness and negative Murphy sign. The patient was started on proton pump inhibitors (PPI). After two weeks, his followup complete blood count, basic metabolic panel, and liver function panel were unremarkable. The patient reported no relief of symptoms with PPI and was referred for endoscopy, which the patient initially refused. He returned to clinic after 2 months with worsening symptoms and further loss of 10 pounds and agreed to have an endoscopy.
EGD demonstrated the squamocolumnar junction at 40 cm with evidence of esophagitis (Figure 1(a)) and diffuse gastritis in the antrum extending to the body with a normal pylorus. A few scattered flat polypoidal lesions were found in the distal duodenum (Figure 1(b)). Biopsies were taken from the esophageal, gastric, and duodenal mucosa. Colonoscopy revealed several diffuse ulcerated focal lesions in the ascending colon and cecum (Figures 2(a) and 2(b)). Biopsies were obtained and sent for pathology. After endoscopic evaluation, suspicion was high for IBD, but no steroids were initiated. Distal duodenal biopsy was stained with Gomori’s Methenamine Silver, revealing acute and chronic inflammation with macrophages and numerous yeast, consistent with Histoplasma capsulatum. Urine histoplasma antigen came back markedly elevated at >20 ng/mL, confirming the diagnosis. Our histoplasmosis urine antigen came back high-positive (not indeterminate) and protocol for high-positive is not set for reflux to confirmatory MiraVista (Indianapolis, Indiana) histoplasma quantitative enzyme immunoassay. Though unlikely, it is possible for other dimorphic fungal pathogens to infect macrophages and potentially cross-react with the urine antigen test (e.g., Blastomyces, Paracoccidioides). However, our high-positive urine antigen test coupled with immunohistochemical evidence of histoplasmosis fully supports the diagnosis. No metaplasia or carcinoma was identified and no organisms were identified on an immunohistochemical stain for Helicobacter. At this stage, HIV screening was ordered and returned positive, with CD4 count of 76 cells/mm3. The patient was started on itraconazole therapy, as well as prophylactic trimethoprim/sulfamethoxazole (TMP/SMX), as his CD4 count was under 200. He will be seen in an outpatient clinic for initiation of ART.
Patients with GIH are usually asymptomatic and diagnosis is often made incidentally or in autopsy finding . It most commonly presents with fever, bloody diarrhea, abdominal pain, and hepatosplenomegaly on exam [3, 4]. Some case reports revealed patients presenting with odynophagia or dysphagia as a result of extrinsic compression from mediastinal adenitis or from mediastinal fibrosis as seen in the primary pulmonary manifestation of histoplasmosis. On endoscopic evaluation, involvement has been seen to occur from the mouth to the rectum. The upper gastrointestinal tract can have oropharyngeal ulceration, perforation, and obstruction . Gastric involvement can range from patchy or continuous superficial ulcerations to deep ulcers with or without perforation . Small bowel involvement is commonly characterized as segmental inflammation and ulceration. The majority (90%) of lesions involve the lower GI tract, most commonly the ileocecal region or colon [4, 6], likely due to this region’s high presence of gut-associated lymphoid tissue (GALT), serving as potential entry sites for macrophages filled with H. capsulatum yeasts [4, 6]. In the largest case series of GIH in AIDS patients. Less than 4% of AIDS patients with GIH demonstrate duodenal disease, further confirming the unusual aspect of our patient’s presentation .
In stable patients, such as the patient in our case, itraconazole treatment for 6 to 18 months may be the initial choice [1, 2]. Prophylaxis with itraconazole is recommended in patients with HIV and CD4 cell counts <150 cells/mm3 in specific areas where the incidence of histoplasmosis is >10 cases per patient-years. Antigen levels should be monitored during and for one year after therapy to ensure that there are no relapses. Our patient responded adequately to itraconazole treatment. It is imperative to wait for pathology results before initiating treatment for possible IBD with steroids, as it may exacerbate infectious processes in AIDS patients.
Disseminated histoplasmosis should be considered in immunocompromised patients, regardless of pulmonary symptoms, in endemic or nonendemic areas. Histoplasma capsulatum can mimic an innumerable amount of syndromes, from other infectious etiologies like tuberculosis to malignancy, PUD, and IBD, leading to inappropriate therapies and unnecessary surgical interventions.
|IBD:||Inflammatory bowel disease|
|PUD:||Peptic ulcer disease|
No financial support or grant was obtained for the project. None of the authors listed received any financial support or services or any other contributions for their work. All patient identifiers have been removed.
The authors declare that they have no competing interests regarding the publication of this paper.
Each of the co-authors contributed to evaluating and/or managing the case and drafting and/or editing the manuscript. Andrew C. Berry is the article guarantor and participated in manuscript drafting, editing, and submission and manuscript leadership. Rahman Nakshabendi, Daisy Torres-Miranda, Francis Daniel LaBarbera, and Ozdemir Kanar were involved in patient care, management, literature review, manuscript drafting, and editing. Ahmad Nakshabandi and Imad Nakshabendi participated in manuscript drafting, editing, and submission.
- G. Psarros and C. A. Kauffman, “Colonic histoplasmosis: a difficult diagnostic problem,” Gastroenterology and Hepatology, vol. 3, no. 6, pp. 461–463, 2007.
- C. A. Kauffman, “Histoplasmosis: a clinical and laboratory update,” Clinical Microbiology Reviews, vol. 20, no. 1, pp. 115–132, 2007.
- S. Jain, J. Koirala, and F. Castro-Pavia, “Isolated gastrointestinal histoplasmosis: case report and review of the literature,” Southern Medical Journal, vol. 97, no. 2, pp. 172–174, 2004.
- M. Assi, D. S. McKinsey, M. R. Driks et al., “Gastrointestinal histoplasmosis in the acquired immunodeficiency syndrome: report of 18 cases and literature review,” Diagnostic Microbiology and Infectious Disease, vol. 55, no. 3, pp. 195–201, 2006.
- J. T. Lee, M. R. Dixon, Z. Murrell et al., “Colonic histoplasmosis presenting as colon cancer in the nonimmunocompromised patient: report of a case and review of the literature,” The American Surgeon, vol. 70, no. 11, pp. 959–963, 2004.
- M. A. Spinner, H. N. Paulin, and C. W. Wester, “Duodenal histoplasmosis presenting with upper gastrointestinal bleeding in an AIDS patient,” Case Reports in Gastrointestinal Medicine, vol. 2012, Article ID 515872, 4 pages, 2012.
Copyright © 2016 Rahman Nakshabendi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.